UnitedHealth's Strategic Growth Focus and Financial Resilience Underpin Buy Rating
Truist Says Near-term Visibility Remains Challenging for UnitedHealth
Nephron Lowers Lowers Price Target on UnitedHealth Group to $368 From $513
Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), UnitedHealth (UNH) and Roche Holding AG (OtherRHHVF)
Mizuho Securities Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $515
Mizuho Adjusts Price Target on UnitedHealth Group to $515 From $650
Erste Group Downgrades UnitedHealth(UNH.US) to Hold Rating
Baird Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $510
UnitedHealth Is Maintained at Outperform by Baird
UnitedHealth Group Analyst Ratings
Baird Lowers Price Target on UnitedHealth Group to $510 From $640
J.P. Morgan Maintains UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $525
UnitedHealth Is Maintained at Overweight by JP Morgan
UnitedHealth Price Target Cut to $525.00/Share From $652.00 by JP Morgan
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $513
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $525
RBC Capital Maintains Outperform on UnitedHealth Group, Lowers Price Target to $525
UnitedHealth Group Analyst Ratings
Barclays Adjusts Price Target on UnitedHealth Group to $513 From $560, Maintains Overweight Rating